Improved Antibodies Against ERBB4/HER4

therapoid

  1. Home
  2. Technologies
  3. Improved Antibodies Against ERBB4/HER4
  4. Summary
Provided by: National Institutes of Health (NIH)
Tags: anti-cancer cancer Breast Cancer GPCR Cell Line
Short Description:

This technology pertains to specific rabbit monoclonal antibodies generated against the ErbB4 receptor (also known as HER4) that have been validated for specificity using tissue sections and extracts from ErbB4 knockout mice.

Projects based on this Technology

Start New Project